ArticleCancer2013

Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma.

Ahmed O Kaseb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.